UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. __ )
MARTEK BIOSCIENCES CORP.
(Name of Issuer)
Common Stock, par value $.10 per share
(Title of Class of Securities)
572901106
(CUSIP Number)
May 28, 1999
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed.
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
1
<PAGE>
CUSIP No. 572901106 13G Page 2 of 6 Pages
- - - - - - - - - - - - - - - - - --------------------------------------------------------------------------------
1. Names of Reporting Persons.
I.R.S. Identification Nos. Of Above Persons (entities only)
George Weaver Haywood
- - - - - - - - - - - - - - - - - --------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [ ]
- - - - - - - - - - - - - - - - - --------------------------------------------------------------------------------
3. SEC Use Only
- - - - - - - - - - - - - - - - - --------------------------------------------------------------------------------
4. Citizenship or Place of Organization
U.S.A.
- - - - - - - - - - - - - - - - - --------------------------------------------------------------------------------
Number of Shares Beneficially Owned by Each Reporting Person With
- - - - - - - - - - - - - - - - - --------------------------------------------------------------------------------
5. Sole Voting Power 1,007,907
- - - - - - - - - - - - - - - - - --------------------------------------------------------------------------------
6. Shared Voting Power -
- - - - - - - - - - - - - - - - - --------------------------------------------------------------------------------
7. Sole Dispositive Power 1,007,907
- - - - - - - - - - - - - - - - - --------------------------------------------------------------------------------
8. Shared Dispositive Power -
- - - - - - - - - - - - - - - - - --------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
1,007,907
- - - - - - - - - - - - - - - - - --------------------------------------------------------------------------------
10. Check box if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions). [ ]
- - - - - - - - - - - - - - - - - --------------------------------------------------------------------------------
11. Percent of Class Represented By Amount in Row (9)
6.1
- - - - - - - - - - - - - - - - - --------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions)
IN
2
<PAGE>
Item 1(a) Name of Issuer:
Martek Biosciences Corp.
Item 1(b) Address of Issuer's Principal Executive Offices:
6480 Dobbin Road, Columbia, Maryland 21045
Item 2(a) Name of Person Filing:
George Weaver Haywood
Item 2(b) Address of Principal Business Office or, if none, Residence:
642 Second Street, Brooklyn, New York 11215
Item 2(c) Citizenship:
U.S.A.
Item 2(d) Title of Class of Securities:
Common Stock, par value .10 per share
Item 2(e) CUSIP Number
572901106
Item 3. If this statement is filed pursuant to Rules 13d-1(b), or
13d-2(b) or (c), check whether the person filing is a:
(a) [ ] Broker or dealer registered under Section 15 of the Act
(15 U.S.C. 78c).
(b) [ ] Bank as defined in Section 3(a)(6) of the Act
(15 U.S.C.78c).
(c) [ ] Insurance company as defined in Section 3(a)(19)
of the Act (15 U.S.C. 78c).
(d) [ ] Investment company registered under Section 8 of
the Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e) [ ] An investment adviser in accordance with Section
240.13d-1(b)(1)(ii)(E).
(f) [ ] An employee benefit plan or endowment fund in
accordance with Section 240.13d-1(b)1(ii)(F).
(g) [ ] A parent holding company or control person in
accordance with Section 240.13d-
3
<PAGE>
1(b)(ii)(G).
(h) [ ] A savings association as defined in Section 3(b)
of the Federal Deposit Insurance Act (12 U.S.C. 1813).
(i) [ ] A church plan that is excluded from the definition
of an investment company under Section 3(c)(14) of the
Investment Company Act of 1940 (15 U.S.C. 80a-3)
(j) [ ] Group, in accordance with Section 240.13d-1(b)(1)(ii)(J).
If this statement is filed pursuant to Rule 13d-1(c), check this box. [X]
Item 4. Ownership.
(a) Amount Beneficially Owned: 1,007,907
(b) Percent of Class: 6.1
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 1,007,907
(ii) shared power to vote or to direct vote: -
(iii) sole power to dispose or to direct the disposition of:
1,007,907
(iv) shares power to dispose or to direct the disposition of:
-
4
<PAGE>
Item 5. Ownership of Five Percent or Less of a Class.
Not applicable
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not applicable
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported On By the Parent Holding Company.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
5
<PAGE>
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not being
held for the purpose of or with the effect of changing or influencing the
control of the issuer of the securities and were not acquired and are not held
in connection with or as a participant in any transaction having that purposes
or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: June 9, 1999
------------------------------------
Signature
George Weaver Haywood
------------------------------------
Name
ATTENTION: INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL
CRIMINAL VIOLATIONS(SEE 18 U.S.C. 1001).
6
